Article: Cord Blood Stem Cells Yielding Clinical Benefits.

The stem cells that are likely to generate the quickest, least expensive, and largest clinical benefits are readily available and present no ethical dilemma.

They are stem cells obtained from umbilical cord blood.

The controversy that surrounded President Bush's decision to fund research involving existing lines of embryonic stem cells has dominated discussions of stem cell research.

Yet in the background, umbilical cord blood cells have been steadily delivering verifiable clinical results. The only limit on their availability has been the technologic expertise that is required to separate and store the stemcells obtained from the umbilicus.

...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!